CNCR vs. DVAL ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Dynamic US Large Cap Value ETF (DVAL)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$15.43
Average Daily Volume
44,891
71
DVAL
Dynamic US Large Cap Value ETF
DVAL Description
Dynamic US Large Cap Value ETF is an exchange traded fund launched by Franklin Resources, Inc. It is managed by Franklin Advisers, Inc. and Brandywine Global Investment Management, LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. It invests in value stocks of large-cap companies, within the market capitalization range of the Russell 1000 Index. The fund employs quantitative analysis to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the Russell 1000 Value Index and the S&P 500 Index. It employs proprietary research to create its portfolio. Dynamic US Large Cap Value ETF was formed on December 27, 2006 and is domiciled in the United States.Grade (RS Rating)
Last Trade
$12.96
Average Daily Volume
10,459
10
Performance
Period | CNCR | DVAL |
---|---|---|
30 Days | -1.91% | -4.38% |
60 Days | -13.51% | 0.13% |
90 Days | 5.56% | 4.17% |
12 Months | 17.25% | 17.15% |
0 Overlapping Holdings
Symbol | Grade | Weight in CNCR | Weight in DVAL | Overlap |
---|
CNCR Overweight 71 Positions Relative to DVAL
Symbol | Grade | Weight | |
---|---|---|---|
GERN | A | 2.87% | |
ACRV | B | 2.63% | |
ELVN | B | 2.13% | |
JANX | A | 1.79% | |
NUVB | B | 1.7% | |
CGEM | A | 1.57% | |
RVMD | A | 1.56% | |
HCM | A | 1.54% | |
TSVT | D | 1.51% | |
DAWN | A | 1.5% | |
BPMC | A | 1.48% | |
MRK | B | 1.48% | |
EXEL | B | 1.47% | |
LYEL | B | 1.46% | |
YMAB | B | 1.43% | |
MOR | C | 1.41% | |
BCYC | B | 1.39% | |
PGEN | C | 1.39% | |
INBX | D | 1.38% | |
ITOS | B | 1.38% | |
IMCR | D | 1.37% | |
MGNX | D | 1.37% | |
NRIX | D | 1.37% | |
IPHA | F | 1.36% | |
AURA | D | 1.34% | |
BNTX | C | 1.33% | |
REGN | C | 1.33% | |
RAPT | F | 1.32% | |
GMAB | F | 1.32% | |
MRUS | B | 1.32% | |
VOR | F | 1.32% | |
BMY | F | 1.31% | |
SDGR | F | 1.31% | |
SNDX | C | 1.29% | |
DCPH | A | 1.29% | |
ACET | F | 1.28% | |
TYRA | B | 1.27% | |
ERAS | D | 1.27% | |
GLUE | D | 1.26% | |
IDYA | C | 1.25% | |
KYMR | C | 1.25% | |
SWTX | D | 1.23% | |
PRLD | D | 1.22% | |
FHTX | D | 1.21% | |
XNCR | B | 1.21% | |
STRO | D | 1.21% | |
KURA | C | 1.2% | |
IMTX | C | 1.19% | |
RCUS | D | 1.18% | |
ZNTL | F | 1.17% | |
IOVA | C | 1.16% | |
KPTI | F | 1.14% | |
NUVL | C | 1.12% | |
DNA | F | 1.12% | |
IGMS | D | 1.1% | |
RLAY | F | 1.09% | |
ACLX | C | 1.07% | |
SMMT | B | 1.06% | |
AUTL | F | 1.04% | |
RXRX | F | 1.03% | |
ARVN | D | 1.02% | |
REPL | F | 1.01% | |
CRBU | F | 1.01% | |
LEGN | D | 0.96% | |
ALLO | F | 0.95% | |
BMEA | F | 0.9% | |
RPTX | F | 0.89% | |
FATE | D | 0.83% | |
MRSN | D | 0.81% | |
GNLX | F | 0.78% | |
IMRX | F | 0.73% |
CNCR: Top Represented Industries & Keywords
DVAL: Top Represented Industries & Keywords